A citation-based method for searching scientific literature

Francis Yew Fu Tieng, Nadiah Abu, Learn-Han Lee, Nurul-Syakima Ab Mutalib. Diagnostics (Basel) 2021
Times Cited: 3







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
100

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
66

High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies.
Amanda Bortolini Silveira, François-Clément Bidard, Amélie Kasperek, Samia Melaabi, Marie-Laure Tanguy, Manuel Rodrigues, Guillaume Bataillon, Luc Cabel, Bruno Buecher, Jean-Yves Pierga,[...]. Clin Chem 2020
15
66

Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities.
Zeina Habli, Walid AlChamaa, Raya Saab, Humam Kadara, Massoud L Khraiche. Cancers (Basel) 2020
25
66

Circulating tumor cell technologies.
Meghaan M Ferreira, Vishnu C Ramani, Stefanie S Jeffrey. Mol Oncol 2016
242
66

A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
Rongbin Liu, Xuan Su, Yakang Long, Dalei Zhou, Xiao Zhang, Zulu Ye, Jiangjun Ma, Tao Tang, Fang Wang, Caiyun He. Mutat Res Rev Mutat Res 2019
21
66


Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.
María José Domper Arnal, Ángel Ferrández Arenas, Ángel Lanas Arbeloa. World J Gastroenterol 2015
398
33

The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments.
Jim F Huggett, Carole A Foy, Vladimir Benes, Kerry Emslie, Jeremy A Garson, Ross Haynes, Jan Hellemans, Mikael Kubista, Reinhold D Mueller, Tania Nolan,[...]. Clin Chem 2013
462
33

Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
Austin M Dulak, Petar Stojanov, Shouyong Peng, Michael S Lawrence, Cameron Fox, Chip Stewart, Santhoshi Bandla, Yu Imamura, Steven E Schumacher, Erica Shefler,[...]. Nat Genet 2013
505
33

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
33

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer.
Yan Wang, Chuanhua Zhao, Lianpeng Chang, Ru Jia, Rongrui Liu, Yun Zhang, Xuan Gao, Jin Li, Rongrong Chen, Xuefeng Xia,[...]. EBioMedicine 2019
29
33

Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer.
Zuhua Chen, Cheng Zhang, Mengqi Zhang, Beifang Li, Yunyun Niu, Limeng Chen, Jing Yang, Sijia Lu, Jing Gao, Lin Shen. Cell Death Dis 2019
9
33

Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
Yunhe Gao, Kecheng Zhang, Hongqing Xi, Aizhen Cai, Xiaosong Wu, Jianxin Cui, Jiyang Li, Zhi Qiao, Bo Wei, Lin Chen. Oncotarget 2017
44
33

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
Eirini Pectasides, Matthew D Stachler, Sarah Derks, Yang Liu, Steven Maron, Mirazul Islam, Lindsay Alpert, Heewon Kwak, Hedy Kindler, Blase Polite,[...]. Cancer Discov 2018
143
33

Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes.
Jaclyn F Hechtman, Satshil Rana, Sumit Middha, Zsofia K Stadler, Alicia Latham, Ryma Benayed, Robert Soslow, Marc Ladanyi, Rona Yaeger, Ahmet Zehir,[...]. Mod Pathol 2020
18
33

Microsatellite Instability as a Biomarker for PD-1 Blockade.
Jonathan C Dudley, Ming-Tseh Lin, Dung T Le, James R Eshleman. Clin Cancer Res 2016
400
33

Clinical significance of circulating plasma DNA in gastric cancer.
Wen-Liang Fang, Yuan-Tzu Lan, Kuo-Hung Huang, Chien-An Liu, Yi-Ping Hung, Chien-Hsing Lin, Fang-Yu Jhang, Shih-Ching Chang, Ming-Huang Chen, Yee Chao,[...]. Int J Cancer 2016
40
33

Neoantigens in cancer immunotherapy.
Ton N Schumacher, Robert D Schreiber. Science 2015
33

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Seung Tae Kim, Razvan Cristescu, Adam J Bass, Kyoung-Mee Kim, Justin I Odegaard, Kyung Kim, Xiao Qiao Liu, Xinwei Sher, Hun Jung, Mijin Lee,[...]. Nat Med 2018
464
33

Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.
Francesca Battaglin, Madiha Naseem, Alberto Puccini, Heinz-Josef Lenz. Cancer Cell Int 2018
29
33

Monitoring gastric cancer progression with circulating tumour DNA.
T Hamakawa, Y Kukita, Y Kurokawa, Y Miyazaki, T Takahashi, M Yamasaki, H Miyata, K Nakajima, K Taniguchi, S Takiguchi,[...]. Br J Cancer 2015
71
33

FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Leigh Marcus, Steven J Lemery, Patricia Keegan, Richard Pazdur. Clin Cancer Res 2019
331
33

Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Raul S Gonzalez, Susan Messing, Xin Tu, Loralee A McMahon, Christa L Whitney-Miller. Hum Pathol 2016
28
33

Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer.
Katsutoshi Shoda, Daisuke Ichikawa, Yuji Fujita, Kiyoshi Masuda, Hidekazu Hiramoto, Junichi Hamada, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Atsushi Shiozaki,[...]. Gastric Cancer 2017
79
33

Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
De-Shen Wang, Ze-Xian Liu, Yun-Xin Lu, Hua Bao, Xue Wu, Zhao-Lei Zeng, Zekun Liu, Qi Zhao, Cai-Yun He, Jia-Huan Lu,[...]. Gut 2019
49
33

Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Klaus Pantel, Catherine Alix-Panabières. Nat Rev Clin Oncol 2019
300
33

Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapy.
Sávia Raquel Costa Normando, Pamela de Oliveira Delgado, Ana Katherine Soares Barbosa Rodrigues, Waldec Jorge David Filho, Fernando Luiz Affonso Fonseca, Felipe José Silva Melo Cruz, Auro Del Giglio. BMC Clin Pathol 2018
12
33

Application of Cell-free DNA Analysis to Cancer Treatment.
Ryan B Corcoran, Bruce A Chabner. N Engl J Med 2018
287
33

Circulating cell-free nucleic acids: characteristics and applications.
Ondrej Pös, Orsolya Biró, Tomas Szemes, Bálint Nagy. Eur J Hum Genet 2018
70
33

Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
Shumei Kato, Ryosuke Okamura, Joel M Baumgartner, Hitendra Patel, Lawrence Leichman, Kaitlyn Kelly, Jason K Sicklick, Paul T Fanta, Scott M Lippman, Razelle Kurzrock. Clin Cancer Res 2018
47
33

Droplet digital PCR measurement of HER2 in patients with gastric cancer.
H Kinugasa, K Nouso, T Tanaka, K Miyahara, Y Morimoto, C Dohi, T Matsubara, H Okada, K Yamamoto. Br J Cancer 2015
52
33

Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Audrey H Choi, Joseph Kim, Joseph Chao. World J Gastroenterol 2015
46
33

Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
Steven B Maron, Leah M Chase, Samantha Lomnicki, Sara Kochanny, Kelly L Moore, Smita S Joshi, Stacie Landron, Julie Johnson, Lesli A Kiedrowski, Rebecca J Nagy,[...]. Clin Cancer Res 2019
54
33

From tumour heterogeneity to advances in precision treatment of colorectal cancer.
Cornelis J A Punt, Miriam Koopman, Louis Vermeulen. Nat Rev Clin Oncol 2017
254
33

Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.
Somayeh Vafaei, Fahimeh Fattahi, Marzieh Ebrahimi, Leila Janani, Ahmad Shariftabrizi, Zahra Madjd. Cancer Manag Res 2019
15
33


Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.
S J Cohen, C J A Punt, N Iannotti, B H Saidman, K D Sabbath, N Y Gabrail, J Picus, M A Morse, E Mitchell, M C Miller,[...]. Ann Oncol 2009
349
33

Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer.
Alexandre Prieur, Monica Cappellini, Guillaume Habif, Marie-Paule Lefranc, Thibault Mazard, Eric Morency, Jean-Marc Pascussi, Maud Flacelière, Nathalie Cahuzac, Bérengère Vire,[...]. Clin Cancer Res 2017
19
33

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
Carmen J Allegra, J Milburn Jessup, Mark R Somerfield, Stanley R Hamilton, Elizabeth H Hammond, Daniel F Hayes, Pamela K McAllister, Roscoe F Morton, Richard L Schilsky. J Clin Oncol 2009
903
33

Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.
Jennifer E Hardingham, Phulwinder Grover, Marnie Winter, Peter J Hewett, Timothy J Price, Benjamin Thierry. Mol Med 2015
75
33

The pre-analytical phase of the liquid biopsy.
Francesca Salvianti, Stefania Gelmini, Filomena Costanza, Irene Mancini, Gemma Sonnati, Lisa Simi, Mario Pazzagli, Pamela Pinzani. N Biotechnol 2020
16
33

Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients.
Wen-Sy Tsai, Jinn-Shiun Chen, Hung-Jen Shao, Jen-Chia Wu, Jr-Ming Lai, Si-Hong Lu, Tsung-Fu Hung, Yen-Chi Chiu, Jeng-Fu You, Pao-Shiu Hsieh,[...]. Sci Rep 2016
87
33

Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Saiyad Bastaminejad, Morovat Taherikalani, Reza Ghanbari, Akbar Akbari, Nooshin Shabab, Massoud Saidijam. Iran Biomed J 2017
29
33

Early detection of colorectal cancer: from conventional methods to novel biomarkers.
Nasimeh Vatandoost, Jahanafrooz Ghanbari, Mahboobeh Mojaver, Amir Avan, Majid Ghayour-Mobarhan, Reza Nedaeinia, Rasoul Salehi. J Cancer Res Clin Oncol 2016
69
33

Technologies for circulating tumor cell separation from whole blood.
Petra Bankó, Sun Young Lee, Viola Nagygyörgy, Miklós Zrínyi, Chang Hoon Chae, Dong Hyu Cho, András Telekes. J Hematol Oncol 2019
84
33

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
Rafael G Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky,[...]. J Clin Oncol 2008
33

Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
Marta Tellez Gabriel, Lidia Rodriguez Calleja, Antoine Chalopin, Benjamin Ory, Dominique Heymann. Clin Chem 2016
120
33

Efficacy of a nationwide screening colonoscopy program for colorectal cancer.
Christian P Pox, Lutz Altenhofen, Hermann Brenner, Arno Theilmeier, Dominik Von Stillfried, Wolff Schmiegel. Gastroenterology 2012
182
33

Circulating cancer stem cells: the importance to select.
Ming-Hsin Yang, Ahmet Imrali, Christopher Heeschen. Chin J Cancer Res 2015
46
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.